share_log
Moomoo 24/7 ·  Apr 16 16:30
TScan Therapeutics Shares Are Trading Lower After the Company Announced That It Commenced a $125 Million Proposed Public Offering. The Company Provided an Update on Its Solid Tumor and Heme Malignancies Clinical Programs
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment